Clinical trial
Dose Escalation Study Evaluating the Safety of Dimethyl Sulfoxide Cryopreserved Platelets Compared With Liquid Stored Platelets in Patients With Uncontrolled Bleeding
NCT02078284 is registered in ClinicalTrials.gov with U.S. Army Medical Research and Development Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Escalation Study Evaluating the Safety of Dimethyl Sulfoxide Cryopreserved Platelets Compared With Liquid Stored Platelets in Patients With Uncontrolled Bleeding
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 5, 2014
- Completion date
- July 17, 2016
- Enrollment
- 28 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.